Agudelo Higuita Nelson Iván, Franco-Paredes Carlos, Henao-Martínez Andrés F, Mendez Rojas Bomar, Suarez José Antonio, Naranjo Laura, Alger Jackeline
Department of Medicine, Section of Infectious Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Instituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras.
Lancet Reg Health Am. 2023 May 6;22:100505. doi: 10.1016/j.lana.2023.100505. eCollection 2023 Jun.
Human migration has shaped the distribution and patterns of infectious diseases transmission throughout history. Migration is one of the contributing factors that has played an important role in the dissemination of drug-resistant . Central America and Mexico are important transit points of an increasing migrant flow originating from countries where chloroquine-resistant . and are prevalent. Surveillance systems, as well as detection and diagnostic capacities in the Central American region, are limited. The additional challenges imposed by the increasingly mobile population in the region are creating the perfect scenario for the emergence or re-emergence of infectious diseases, such as the introduction of chloroquine-resistant malaria. The development and implementation of transborder, collaborative, and ethical migrant health initiatives in the region are urgently needed. The health of migrant people in transit during their migratory route is of our collective interest and responsibility; their exclusion from health programs based on their legal status contradicts international human rights treaties and is inconsistent with ethical global public health practice.
在历史进程中,人类迁徙塑造了传染病传播的分布和模式。迁徙是耐药性传播的一个重要促成因素。中美洲和墨西哥是来自氯喹耐药现象普遍国家的日益增多的移民潮的重要中转站。中美洲地区的监测系统以及检测和诊断能力有限。该地区人口流动性不断增加带来的额外挑战,正为传染病的出现或再次出现创造了完美的条件,例如耐氯喹疟疾的传入。该地区迫切需要制定和实施跨境、协作且符合道德规范的移民健康倡议。移民在迁徙途中的健康关乎我们的共同利益和责任;基于其法律地位将他们排除在健康项目之外,既违背国际人权条约,也不符合符合道德规范的全球公共卫生实践。